Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Ari Hakimi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Urologic Oncology|August 6, 2020
Introduction to high throughput platforms in kidney cancer: Genomics, transcriptomics, and metabolomics urologic oncology: Seminars and original investigationsAbraham Ari Hakimi
Current Opinion in Urology|July 29, 2016
Molecular profiling of renal cell carcinoma: building a bridge toward clinical impactBrandon J Manley, Abraham Ari Hakimi
Cancers|January 21, 2023
Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma: A Critical Analysis of the Current LiteratureLina Posada Calderon, Lennert Eismann, Stephen W Reese, et al.
Urologic Oncology|June 2, 2018
The natural history of large renal masses followed on observationKarim Marzouk, Amy Tin, Nick Liu, et al.
Elife|December 1, 2018
Rejection of immunogenic tumor clones is limited by clonal fractionRon S Gejman, Aaron Y Chang, Heather F Jones, et al.
Urologic Oncology|January 23, 2016
The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cmRoy Mano, Emily A Vertosick, Abraham Ari Hakimi, et al.
Urology|April 16, 2015
Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical TumorsRoy Mano, Matthew Kent, Yaniv Larish, et al.
Clinical Genitourinary Cancer|December 3, 2025
Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center ExperienceLennert Eismann, Stephen W Reese, Mark T Dawidek, et al.
The Journal of Urology|August 9, 2022
Reply by AuthorsHarshit Garg, Sarah P Psutka, Abraham Ari Hakimi, et al.
The Journal of Urology|August 9, 2022
Reply by AuthorsHarshit Garg, Sarah P Psutka, Abraham Ari Hakimi, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Urologic Oncology|August 6, 2020
Introduction to high throughput platforms in kidney cancer: Genomics, transcriptomics, and metabolomics urologic oncology: Seminars and original investigationsAbraham Ari Hakimi
Current Opinion in Urology|July 29, 2016
Molecular profiling of renal cell carcinoma: building a bridge toward clinical impactBrandon J Manley, Abraham Ari Hakimi
Cancers|January 21, 2023
Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma: A Critical Analysis of the Current LiteratureLina Posada Calderon, Lennert Eismann, Stephen W Reese, et al.
Urologic Oncology|June 2, 2018
The natural history of large renal masses followed on observationKarim Marzouk, Amy Tin, Nick Liu, et al.
Elife|December 1, 2018
Rejection of immunogenic tumor clones is limited by clonal fractionRon S Gejman, Aaron Y Chang, Heather F Jones, et al.
Urologic Oncology|January 23, 2016
The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cmRoy Mano, Emily A Vertosick, Abraham Ari Hakimi, et al.
Urology|April 16, 2015
Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical TumorsRoy Mano, Matthew Kent, Yaniv Larish, et al.
Clinical Genitourinary Cancer|December 3, 2025
Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center ExperienceLennert Eismann, Stephen W Reese, Mark T Dawidek, et al.
The Journal of Urology|August 9, 2022
Reply by AuthorsHarshit Garg, Sarah P Psutka, Abraham Ari Hakimi, et al.
The Journal of Urology|August 9, 2022
Reply by AuthorsHarshit Garg, Sarah P Psutka, Abraham Ari Hakimi, et al.
Pageof 2